ATC code None PubChem CID 11513676 KEGG D10087 Molar mass 1,216.64 g/mol | CAS Number 254435-95-5 ChemSpider 9688467 ChEMBL CHEMBL1651956 | |
 | ||
How to pronounce alisporivir
Alisporivir (INN), or Debio 025, DEB025, (or UNIL-025) is a cyclophilin inhibitor. Its structure is reminiscent of, and synthesized from ciclosporin.
It inhibits cyclophilin A. Alisporivir is not immunosuppressive.
It is being researched for potential use in the treatment of hepatitis C. It has also been investigated for Duchenne muscular dystrophy.
Alisporivir is under development by Debiopharm for Japan and by Novartis for the rest of the world (licence granted by Debiopharm) since February 2010.
References
Alisporivir Wikipedia(Text) CC BY-SA